2012 Conference Schedule
Current Trends in Cardiovascular Disease XIV
April 14, 2012
Spokane Convention Center
334 W Spokane Falls Blvd, Spokane, WA
 
7:00 am-8:00 am – Registration, Continental Breakfast, Visit Exhibitors
8:00 am Introduction - Guy E Katz MD FACC Program Director
 
Session 1: Challenges In Screening and Treatments
 
8:15 am-8:45 am - Chest Pain and Syncope in the Pre Adolescent
C. Chris Anderson, MD - Northwest Pediatric Cardiology
  • Apply risk stratification concepts to clinical scenarios
  • Choose the proper diagnostic cardiac testing
  • Refer children appropriately to a Cardiologist?
8:45 am-9:15 am Cardiac Biomarkers – Pearls and Pitfalls of Use
Pierre Leimgruber MD FACC – Providence Spokane Heart Institute
  • Understand diagnostic and prognostic value
  • Recognize causes for false positive test results
  • Treating “test results”

9:15 am-9:45 am Mazes in Lipid Management – Choices and Challenges
Bryan Fuhs MD FACC – Providence Spokane Heart Institute

  • Review current guidelines for Secondary Prevention
  • Discuss challenges to achieving guidelines; New Warnings
  • Treatment Pearls for improved outcomes
9:45 am-10:15 am Cardiac Diagnosis in Women: Approaches to Clinical Scenarios
Janice Christensen MD FACC Providence Spokane Heart Institute
  • Review clinical presentations of cardiac problems in women
  • Discuss differential diagnosis and testing options
Morning Break 10:15-10:45
 
Session 2: Challenges in Congestive Heart Failure
10:45 am-11:15 am - Heart Failure with Preserved LV Function - A growing Epidemic
Andrew Boulet MD FACC – Providence Spokane Heart Institute
  • Pathophysiology of HFpER and Clinical Recognition
  • Discuss different therapeutic options vs Systolic Heart Failure
  • Prognostic considerations – Can they be modified with treatment

11:15 am-11:45 am- Device Therapy for CHF: AICD and Biventricular Pacing
Gerhard Muelheims MD FACC – Providence Spokane Heart Institute

  • Understand patient subsets for which device therapy may benefit
  • Primary Care Issues for patients with Cardiac Resynchronization Therapy (CRT) and Automatic Implantable Cardiac Defibrillators (AICD) –

11:45 am-12:15 pm - “Failure in Treating Heart Failure” Evolving Role for Mechanical Support Devices
Andrew Coletti MD FACC – PeaceHealth Medical Group

  • Review ACC stages of heart failure with particular focus on identifying patients with ACC stage D heart failure
  • Review indications for advanced heart failure therapies- ie. Left VAD, total artificial heart, and cardiac transplantation.
  • Review the role of the multidisciplinary advanced heart failure team in caring for patients with Stage D heart failure.

12:15-1:00 PM Buffet Lunch and Visit Exhibits
 
 
Session 3: Clots and Clogging

1:00 pm-1:15 pm - Medical Therapy for “Clots”– New Antiplatelet and Antithrombotic Treatment
Dieter Lubbe MD, FACC– Providence Spokane Heart Institute

  • Antiplatelet Therapy Options – Current and Future
  • Recognition of the “non responders”- Clinical implications
  • Newer Anticoagulation Options

1:15 pm-1:45 pm - Atrial Emboli – New Treatment Options for PFO and Atrial Appendages
Philip Huber MD FACC – Providence Spokane Heart Institute

  • Patent Foramen Ovale – Indications for Intervention
  • Atrial Appendage Thrombi – Role for Occlusion Devices  

1:45 pm – 2:15 pm - The Initial Evaluation of Arterial and Venous Insufficiency-Practical Screening and Treatment
Joe Davis MD – Inland Vascular Institute

  • Review the differential diagnosis and evaluation of patients presenting in an office setting with PAD (Spectrum from asymptomatic-claudication-critical ischemia)
  • Review exercise, pharmacologic, endovascular and surgical options for treatment
  • Proper recognition of patients with venous insufficiency and treatment options
2:30 -2:50 PM Refreshment Break and Visit Exhibits
 
Session 4: Evolving Treatments in Valvular Heart Disease
 
2:50 pm – 3:20 pm - Interventional Cardiology – New Frontiers
Susan Alexander MD FACC – Providence Spokane Heart Institute
  • Analyze the treatment limitations for certain cardiac and vascular problems.
  • Assess the recent scientific presentations of novel and evolving technologies for percutaneous treatment options

3:20 pm – 3:50 pm - Transcatheter Aortic Valve Replacements
Michael Ring MD FACC – Providence Spokane Heart Institute
Branden Reynolds MD – NW Heart & Lung Surgical Associates

  • Evaluate new percutaneous treatments for valvular heart disease
  • Considerations for patient selection
  • What are “good outcomes” for a “high risk patient”?  

3:50 pm - 4 pm - Closing remarks, survey collection, and CME certificates

©2012 Northwest Cardiovascular Research Institute. All Rights Reserved. Website by Lulliloo Design.